Kerry Mullaney

5.9k total citations · 2 hit papers
24 papers, 1.5k citations indexed

About

Kerry Mullaney is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kerry Mullaney has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Kerry Mullaney's work include Sarcoma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Kerry Mullaney is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Kerry Mullaney collaborates with scholars based in United States, Canada and Chile. Kerry Mullaney's co-authors include Ryma Benayed, Marc Ladanyi, Alexander Drilon, David M. Hyman, Ahmet Zehir, Ralph A. Nixon, Ying Jiang, Corrinne M. Peterhoff, Paul M. Mathews and Anne M. Cataldo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kerry Mullaney

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls

2019 366 citations James P. Solomon, Irina Linkov et al. Modern Pathology profile →
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden

2019 289 citations Ryma Benayed, Michael Offin et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerry Mullaney United States	13	670	501	463	362	275	24	1.5k
Simone Hettmer Germany	23	508 0.8×	270 0.5×	714 1.5×	193 0.5×	129 0.5×	62	1.3k
Yuriko Saiki Japan	21	324 0.5×	432 0.9×	726 1.6×	289 0.8×	85 0.3×	55	1.4k
Frédérique Keslair France	16	947 1.4×	404 0.8×	353 0.8×	177 0.5×	101 0.4×	20	1.4k
Sabrina Rossi Italy	24	1.0k 1.5×	636 1.3×	1.0k 2.2×	483 1.3×	67 0.2×	55	2.5k
Rebecca A. Gladdy Canada	21	854 1.3×	682 1.4×	337 0.7×	173 0.5×	42 0.2×	71	1.7k
Outi Vierimaa Finland	16	429 0.6×	265 0.5×	759 1.6×	358 1.0×	96 0.3×	21	1.7k
Luisa Cironi Switzerland	16	822 1.2×	571 1.1×	1.2k 2.5×	486 1.3×	88 0.3×	22	2.0k
Marjolijn C.J. Jongmans Netherlands	24	426 0.6×	295 0.6×	868 1.9×	172 0.5×	79 0.3×	69	1.8k
John B. McIntyre Canada	19	278 0.4×	208 0.4×	538 1.2×	235 0.6×	71 0.3×	37	1.4k
Kyle Niessen Canada	15	292 0.4×	541 1.1×	1.5k 3.1×	365 1.0×	90 0.3×	17	2.0k

Countries citing papers authored by Kerry Mullaney

Since Specialization

Citations

This map shows the geographic impact of Kerry Mullaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Mullaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Mullaney more than expected).

Fields of papers citing papers by Kerry Mullaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry Mullaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Mullaney. The network helps show where Kerry Mullaney may publish in the future.

Co-authorship network of co-authors of Kerry Mullaney

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry Mullaney. A scholar is included among the top collaborators of Kerry Mullaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry Mullaney. Kerry Mullaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghossein, Ronald, Snjezana Doğan, Kerry Mullaney, et al.. (2025). Expanding the histologic spectrum of thyroid neoplasms with NTRK1/2/3 or ALK translocation: a single-center retrospective study of 82 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(5). 1091–1102.

Chu, Ying‐Hsia, Nora Katabi, Purvil Sukhadia, et al.. (2024). Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions. Histopathology. 86(5). 728–741. 1 indexed citations

Dermawan, Josephine K., Yanming Zhang, Chad Vanderbilt, et al.. (2024). Detection of GRM1 gene rearrangements in chondromyxoid fibroma: a comparison of fluorescence in‐situ hybridisation, RNA sequencing and immunohistochemical analysis. Histopathology. 85(6). 889–898. 3 indexed citations

Boroujeni, Amir Momeni, Kerry Mullaney, Mario M. Leitão, et al.. (2024). Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas. Modern Pathology. 37(5). 100474–100474. 7 indexed citations

Benhamida, Jamal, Deqin Ma, Christopher William, et al.. (2023). Recurrent TRAK1::RAF1 Fusions in pediatric low‐grade gliomas. Brain Pathology. 33(5). e13185–e13185. 3 indexed citations

Chu, Ying‐Hsia, Soo‐Ryum Yang, Jason C. Chang, et al.. (2022). Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations. Journal of Molecular Diagnostics. 24(6). 642–654. 14 indexed citations

Dermawan, Josephine K., Kerry Mullaney, Purvil Sukhadia, et al.. (2022). ALK‐rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors. Genes Chromosomes and Cancer. 62(2). 75–84. 17 indexed citations

Dermawan, Josephine K., Purvil Sukhadia, Kerry Mullaney, et al.. (2022). Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity. Genes Chromosomes and Cancer. 62(4). 191–201. 10 indexed citations

Hosseini, Hossein, Oana Vele, Pamela D. Unger, et al.. (2022). Uterine Leiomyosarcoma with a Novel RAB2A-PLAG1 Gene Fusion. American Journal of Clinical Pathology. 158(Supplement_1). S88–S89.

10.

Ferguson, Donna C., Douglas A. Mata, Timothy Kwang Yong Tay, et al.. (2021). Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations. Modern Pathology. 35(3). 396–402. 16 indexed citations

11.

Yang, Soo‐Ryum, Umut Aypar, Ezra Y. Rosen, et al.. (2020). A Performance Comparison of Commonly Used Assays to Detect RET Fusions. Clinical Cancer Research. 27(5). 1316–1328. 50 indexed citations

12.

Zhang, Lingxin, Sinchun Hwang, Ryma Benayed, et al.. (2020). Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion. Modern Pathology. 33(8). 1492–1504. 21 indexed citations

13.

Benayed, Ryma, Michael Offin, Kerry Mullaney, et al.. (2019). High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden. Clinical Cancer Research. 25(15). 4712–4722. 289 indexed citations breakdown →

14.

Solomon, James P., Irina Linkov, Kerry Mullaney, et al.. (2019). NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Modern Pathology. 33(1). 38–46. 366 indexed citations breakdown →

15.

Cocco, Emiliano, Jamal Benhamida, Sumit Middha, et al.. (2019). Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions. Cancer Research. 79(6). 1047–1053. 100 indexed citations

16.

Benayed, Ryma, Michael Offin, Kerry Mullaney, et al.. (2018). Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays.. Journal of Clinical Oncology. 36(15_suppl). 12076–12076. 4 indexed citations

17.

Zhu, Guo, Ryma Benayed, Caleb Ho, et al.. (2018). Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Modern Pathology. 32(5). 609–620. 116 indexed citations

18.

Wang, Lu, Klaus J. Busam, Ryma Benayed, et al.. (2017). Identification of NTRK3 Fusions in Childhood Melanocytic Neoplasms. Journal of Molecular Diagnostics. 19(3). 387–396. 36 indexed citations

19.

Jiang, Ying, Kerry Mullaney, Corrinne M. Peterhoff, et al.. (2009). Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition. Proceedings of the National Academy of Sciences. 107(4). 1630–1635. 239 indexed citations

20.

Cataldo, Anne M., Paul M. Mathews, Linda Hassinger, et al.. (2008). Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology. American Journal Of Pathology. 173(2). 370–384. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact